-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Augmedix (AUGX) Stock Down 41% Today?
Augmedix stock is down on Tuesday as investors in AUGX shares are unimpressed with the company's updated revenue outlook for 2024!
Why Is Inotiv (NOTV) Stock Down 35% Today?
Inotiv stock is down on Tuesday after the company posted preliminary earnings results that failed to impress NOTV investors.
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
TransCode Therapeutics stock is down on Monday after the company announced plans for a shareholder meeting for RNAZ investors.
Why Is AC Immune (ACIU) Stock Up 45% Today?
AC Immune stock is up on Monday after as investors in ACIU react to a new collaboration agreement with Takeda Pharmaceutical.
Why Is Tevogen Bio (TVGN) Stock Up 54% Today?
Tevogen Bio stock is up on Monday with heavy trading of TVGN stock after securing $50 million in new financing from a current investor.
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
Novavax stock is heading higher on Friday as NVAX investors celebrate it reaching a new 52-week high following a deal with Sanofi.
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
NVAX stock is rising higher after the biotechnology company announced that it had signed a licensing deal with Sanofi.
Why Is Macrogenics (MGNX) Stock Down 69% Today?
Macrogenics stock is down on Friday as MGNX investors react to clinical trial deaths and missed earnings for the first quarter of 2024.
Why Is Novavax (NVAX) Stock Up 118% Today?
Novavax stock is up on Friday after the vaccine company announced a licensing agreement with Sanofi as its Q1 earnings report.
Why Is CytomX (CTMX) Stock Down 43% Today?
CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update.